Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices.
about
The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer.Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer.
P2860
Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Epidermal growth factor recept ...... ication for treatment choices.
@ast
Epidermal growth factor recept ...... ication for treatment choices.
@en
type
label
Epidermal growth factor recept ...... ication for treatment choices.
@ast
Epidermal growth factor recept ...... ication for treatment choices.
@en
prefLabel
Epidermal growth factor recept ...... ication for treatment choices.
@ast
Epidermal growth factor recept ...... ication for treatment choices.
@en
P2860
P356
P1433
P1476
Epidermal growth factor recept ...... lication for treatment choices
@en
P2093
António Araújo
Ramon Andrade De Mello
P2860
P356
10.6061/CLINICS/2012(11)22
P577
2012-11-01T00:00:00Z